Advanced Proteome Therapeutics Corporation reported earnings results for the third quarter and nine months ended April 30, 2022. For the third quarter, the company reported net loss was USD 0.467849 million compared to USD 1.67 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.05 a year ago.
For the nine months, net income was USD 0.835772 million compared to net loss of USD 1.99 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.07 a year ago.